Revised forecast
Fiscal year ending March 2027 · Second quarter (interim period) and full yearPrevious forecast published 12 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
Net sales exceeded the previous forecast as the industrial equipment market and medical equipment market remained strong. Profit also exceeded the previous forecast due to expanded sales to the industrial equipment market, an improved sales mix, and higher profitability resulting from increased sales. The full-year forecast was revised based on the results for the first half and the outlook going forward.
| Item | Details |
|---|---|
| Net Sales | Second quarter (interim period) 6,800 / Full year 13,600 → Second quarter (interim period) 7,000 / Full year 13,800（Second quarter (interim period) 2.9 / Full year 1.5） |
| Operating profit | Second quarter (interim period) 80 / Full year 230 → Second quarter (interim period) 140 / Full year 290（Second quarter (interim period) 75 / Full year 26.1） |
| Ordinary income | Second quarter (interim period) 100 / Full year 250 → Second quarter (interim period) 170 / Full year 320（Second quarter (interim period) 70 / Full year 28） |
| Profit attributable to owners of the parent | Second quarter (interim period) 50 / Full year 120 → Second quarter (interim period) 60 / Full year 130（Second quarter (interim period) 20 / Full year 8.3） |
| Net income per share | Second quarter (interim period) 6.88 / Full year 16.51 → Second quarter (interim period) 8.25 / Full year 17.87 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Second quarter (interim period) and full year |
| Publication date of previous forecast | 12 May 2026 |
| Previous-period results | Fiscal year ended March 2026: net sales ¥12,857 million, operating profit ¥284 million, ordinary profit ¥384 million, net income attributable to owners of the parent ¥210 million, earnings per share ¥28.92 |
| Reason for the revision | Net sales exceeded the previous forecast as the industrial equipment market and medical equipment market remained strong. Profit also exceeded the previous forecast due to expanded sales to the industrial equipment market, an improved sales mix, and higher profitability resulting from increased sales. The full-year forecast was revised based on the results for the first half and the outlook going forward. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales exceeded the previous forecast as the industrial equipment market, including semiconductor manufacturing equipment and factory automation equipment, and the medical equipment market, including ultrasonic endoscopes and ultrasound diagnostic equipment, remained strong. Profit also exceeded the previous forecast due to expanded sales to the industrial equipment market, an improved sales mix, and higher profitability resulting from increased sales. The full-year forecast was revised based on the results for the first half and the outlook going forward.